Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate vs methylphenidate plus saffron in ADHD
IRCT20190602043790N2Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylphenidate and saffron in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Lorestan University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
methylphenidatesaffron
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20190602043790N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190602043790N2.